Chad vs Europe (WHO region): Hepatitis B surface antigen (HBsAg) prevalence (%)
Chad
2.2%
in 2024
Europe (WHO region)
0.1%
in 2024
Chad rank
11th
Europe (WHO region) rank
10th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Chad
- Europe (WHO region)
How they compare
Chad currently reports 2.2% against 0.1% in Europe (WHO region), a difference of 2.1%.
That makes Chad's figure about 22.0 times Europe (WHO region)'s.
Across all 10 years both countries report, Chad has been ahead every year.
Chad ranks 11th and Europe (WHO region) ranks 10th of 194 countries.
Chad has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chad | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.1% | 0.1% | 4.0% | Chad |
| 2020s | 3.0% | 0.1% | 2.9% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Chad or Europe (WHO region)?
- Chad, at 2.2% against 0.1% in Europe (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Chad and Europe (WHO region)?
- 2.1%, with Chad ahead.
- How many years of comparable data are there for Chad and Europe (WHO region)?
- 10 years are reported by both, from 2015 to 2024.
- How do Chad and Europe (WHO region) rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Chad ranks 11th and Europe (WHO region) ranks 10th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.